These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 4881072)
61. [The economic effectiveness of using live measles vaccine]. Popov VF; Ivannikov IuG; Luk'ianov IuV Zh Mikrobiol Epidemiol Immunobiol; 1972 Aug; 49(8):37-9. PubMed ID: 4117530 [No Abstract] [Full Text] [Related]
62. The use of the screening technique as a method of rapidly estimating vaccine efficacy. Hatton P Public Health; 1990 Jan; 104(1):21-5. PubMed ID: 2359815 [TBL] [Abstract][Full Text] [Related]
63. [MEASLES VACCINATION WITH A LIVE ATTENUATED VACCINE (SCHWARZ STRAIN)]. BOUE A; CELERS J Arch Gesamte Virusforsch; 1965; 16():279-83. PubMed ID: 14322878 [No Abstract] [Full Text] [Related]
64. Measles and vaccine protection. Jackson GA Br Med J; 1979 Aug; 2(6185):332. PubMed ID: 476449 [No Abstract] [Full Text] [Related]
65. Comparative study of live attenuated and further attenuated measles vaccines in rural areas of Iran. Naficy K; Saidi S; Nategh R; Mostatab A; Akbarshahy E Arch Gesamte Virusforsch; 1967; 22(1):11-22. PubMed ID: 4879874 [No Abstract] [Full Text] [Related]
66. A comparative field trial of five measles vaccines produced in human diploid cell, MRC-5. Mirchamsy H; Shafyi A; Bahrami S; Kamali M; Nazari P; Razavi F; Ahourai P; Fatemi S; Amin-Salehi M J Biol Stand; 1977; 5(1):1-18. PubMed ID: 838748 [No Abstract] [Full Text] [Related]
67. PREVENTION OF MEASLES BY USE OF LIVE VACCINES IN THE U. S. S. R. SMORODINTSEV AA; BOYCHUK LM; SHIKINA ES; MESHALOVA VN; TAROS LY; AMINOVA MG; REVENOK ND; SAFAROV DI Arch Gesamte Virusforsch; 1965; 16():284-93. PubMed ID: 14322880 [No Abstract] [Full Text] [Related]
68. Reactions to live measles vaccine in children previously given killed measles vaccine. Harris MJ Med J Aust; 1967 Nov; 2(22):989-90. PubMed ID: 6081091 [No Abstract] [Full Text] [Related]
69. Measles and vaccine protection. Preblud SR Br Med J; 1979 Oct; 2(6197):1072. PubMed ID: 519285 [No Abstract] [Full Text] [Related]
70. [CLINICAL COURSE OF MEASLES AND REACTIONS TO ADMINISTRATION OF LIVE MEASLES VACCINE]. KUZMICHEVA AT; BYSTRIAKOVA LV; MATIUSHINA NV Vopr Okhr Materin Det; 1964 Feb; 9():9-13. PubMed ID: 14158855 [No Abstract] [Full Text] [Related]
71. Measles vaccine: titre and safety. Silobrcić V Science; 1993 Jan; 259(5094):441. PubMed ID: 8481200 [No Abstract] [Full Text] [Related]
72. Measles vaccine: titre and safety. Garenne M Science; 1993 Jan; 259(5094):441-2. PubMed ID: 8424160 [No Abstract] [Full Text] [Related]
73. Severe measles in the tropics. II. Morley D Br Med J; 1969 Feb; 1(5640):363-5. PubMed ID: 4387546 [No Abstract] [Full Text] [Related]
74. A collaborative study to assess the proficiency of laboratory estimates of potency of live measles vaccines. Forsey T; Heath AB; Minor PD Biologicals; 1992 Sep; 20(3):233-42. PubMed ID: 1457108 [TBL] [Abstract][Full Text] [Related]